This inventor holds 2 USPTO granted patents. Top assignee: Johns Hopkins University. Active years: 2015-2016.
Location History:
- Baltimore, MD (US) (2015)
- Bonn, DE (2016)
Company Filing History:
Years Active: 2015-2016
Title: Michael Francis Freeman: Innovator in Enzyme Research
Introduction
Michael Francis Freeman is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of enzyme research, particularly in the study of carbapenems. With a total of 2 patents, Freeman's work has implications for antibiotic development and biochemistry.
Latest Patents
Freeman's latest patents focus on the ThnG and ThnQ enzymes encoded by the thienamycin gene cluster. These enzymes are responsible for the oxidation of the C-2 and C-6 moieties of carbapenems. ThnQ stereospecifically hydroxylates PS-5, resulting in the production of N-acetyl thienamycin. Meanwhile, ThnG catalyzes the sequential desaturation and sulfoxidation of PS-5, yielding PS-7 and its sulfoxide. The selective nature of these enzymes contributes to the oxidative diversity of carbapenems, showcasing their potential in pharmaceutical applications.
Career Highlights
Freeman is affiliated with Johns Hopkins University, where he continues to advance his research in enzymology. His work has garnered attention for its innovative approach to understanding enzyme functions and their applications in drug development.
Collaborations
Freeman has collaborated with esteemed colleagues such as Craig Arthur Townsend and Micah Jeffrey Bodner. These partnerships have further enriched his research and contributed to the advancement of knowledge in the field.
Conclusion
Michael Francis Freeman's contributions to enzyme research and his innovative patents highlight his role as a key figure in the scientific community. His work not only enhances our understanding of enzymatic processes but also paves the way for future advancements in antibiotic development.